Palomares MR, Pratt KD, Lehman CD, McTiernan A. "Mammographic density correlates with the Gail model: Implications for a new marker of breast cancer risk," Proc Amer Soc Clin Oncol, 1689, 2001.
Palomares MR, Pratt KD, Machia JRB, Lehman CD, Yasui Y, McTiernan A. "Tamoxifen modifies mammographic density, a noninvasive marker of breast cancer risk," Breast Cancer Res Treat 2001; 133.
Palomares MR, Kussick SJ, Koehler KM, Sabath DE. Development of a method to quantify breast cancer cells in the peripheral blood: comparison of quantitative real-time RT-PCR and flow cytometry using positive versus negative epithelial enrichment methods. Int J Bio Markers, 17(S2): S45, 2002.
Palomares MR, Richardson-Lander A, Koehler KM, Gralow JR, Sabath DE. Quantitative real-time RT-PCR for the detection of circulating breast cancer cells: correlation with stage and treatment. Breast Cancer Res Treat 2002; 217.
Bowen D, Fann J, Andersen R, Rhew I, Gralow J, McTiernan A, Lewis FM, Hunt J, Palomares M, Moinpour C, Pauler D. Feasibility of survivorship research in breast cancer families Proc Amer Assoc Prev Oncol 2003.
Palomares MR, Mandel LS, Lewis FM, Bowen DJ. “Breast cancer genetics, risk, and prevention: Quality of information on the internet," Proc Amer Soc Clin Oncol, 22:2236, 2003.
Palomares MR, Aiello E, Lehman CD, Gralow JR, McTiernan A. Mammographic Breast Density as a Noninvasive Surrogate Marker of Breast Cancer Risk: A Comparison of Density Assessment Methods. Proc Amer Assoc Cancer Res (1st ed), 44:2900, 2003.
Palomares MR, Goldstein L, Lehman CD, Hopper L, Gralow JR. Feasibility of breast tissue sampling in a chemoprevention trial with histologic biomarker endpoints. Breast Cancer Res Treat, 82 (Suppl 1): 1034, 2003.
Palomares MR, Hopper L, Goldstein L, Lehman CD, Gralow JR. Acceptability of breast core biopsy as a tissue sampling method for a chemoprevention trial. Proc Amer Assoc Cancer Res, 45:1344, 2004
Palomares MR, Hopper L, Lehman CD, Storer BE, Gralow JR. Effect of Phytoestrogens on Menopausal Symptoms in Breast Cancer Survivors. Proc Soc Integrative Onc, 75, 2004.
Palomares MR, Hopper L, Goldstein L, Lehman CD, Storer BE, Gralow JR. Effect of Soy Isoflavones on Breast Proliferation in Postmenopausal Breast Cancer Survivors. Breast Cancer Res Treat, 88 (Suppl 1): 4002, 2004.
Palomares MR, Paz IB, Weitzel JN. Genetic Cancer Risk Assessment in the Newly Diagnosed Breast Cancer Patient is Useful and Possible in Practice. J Clin Onc, 23 (13): 3165-3166, 2005.
Hur G, Phung S, Oh S, Kwok S, Sarter B, Palomares M, Weitzel J, and Chen S. Breast cancer prevention with phytochemicals in grape seed extract. Proc Amer Assoc Cancer Res, 46:4278, 2005.
Weitzel JN, Hendrickson B, Lagos V, Lowstuter K, Herzog J, Ho J, Palomares MR, Blazer K, Gonzalez K, Scholl T. Identification of a Frequent Large Genomic Rearrangement of BRCA1 in High-risk Hispanic Families. Proc Amer Soc Hum Gen, 362, 2005.
Palomares MR, Schuster G, Thomas AK, Koehler KM, Gralow JR, Sabath DE. Monitoring Circulating Breast Cancer Cells by Quantitative Real Time RT-PCR. Breast Cancer Res Treat, 94 Supp 1:1018, 2005.
Palomares MR, Machia JRB, Lehman CD, Daling J, McTiernan A. “Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors," Cancer Epidemiol Biomarkers Prev, 15 (7): 1324-30, 2006.
Bowen DJ, Fann JR, Andersen MR, Rhew I, Gralow J, Lewis FM, Hunt J, Palomares MR, Moinpour C, Pauler D. Recruiting clinical patients to behavioral research in the post-HIPPA period. Oncol Nurs Forum (in press).
Ricker CN, Lagos V, Hiyama S, Feldman N, Fuentes S, Kumar V, Gonzalez K, Palomares MR, Blazer K, Lowstuter K, MacDonald M, Weitzel JN. If We Build It Will They Come? – Establishing an Underserved Genetic Cancer Risk Assessment Clinic in a Predominantly Latina Cohort. Journal of Genetic Counseling (in press).
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.
